CPHI North America a ‘one stop shop’ for professional and business development
CPHI events are renowned for connecting pharma players from across the supply chain to learn, grow, and conduct business all over the world.
This year’s North America event returns as a SMART model, with online learning and networking from May 9-27 and an in-person event from May 17-19 in Philadelphia, PA.
Attendees can look forward to a packed agenda of learning labs, panel discussions and presentations, where industry trends are discussed by some of the most prominent voices in pharma. Networking opportunities are baked into the event’s structure, encouraging participants to form connections with stakeholders throughout the supply chain.
According to Wayne Weiner, president of the strategy consultancy Pharmatech Solutions LLC, this access to industry professionals and business development opportunities makes CPHI the ideal ‘one stop shop’ for pharma professionals. Weiner will act as a moderator during two panel discussions this year, one on continuous manufacturing and one on supply chains.
He tells us why he is returning to Philadelphia, previews his panel topics and reveals what he is most looking forward to this year.
Register for CPHI North America here.
Firstly, what are you looking forward to most at CPHI NA this year?
CPHI NA serves as a significant mid-year opportunity to network with colleagues across the industry, learn about significant trends impacting our industry, and in general develop new business opportunities.
What should our attendees expect when attending CPHI?
The opportunity to establish connections with a broad range of industry experts and suppliers, and refresh one’s understanding of the industry.
We have a packed programme with innovative content throughout the 3 on-site days. Is there a particular session you are excited about? If so, why should people attend?
Apart from the sessions I am directly involved with, I am most interested to hear about macro trends that impact the pharma industry (such as drug pricing), and topics relating to M&A.
You will be moderating a panel about rethinking the supply chain at CPHI NA. What do you think are some of the barriers to pharmaceutical manufacturing in the US?
One should keep in mind that there is a significant level of pharmaceutical manufacturing in the US, and this will remain the case. The key issue is how this should be ‘adjusted’ going forward to balance the risk (real or perceived) in the global supply chain vs economic considerations (pricing, investment, etc.)
You will also be moderating a panel on drug manufacturing dynamics at CPHI NA. What do you think is driving the adoption of continuous manufacturing?
Efficiencies in time to market, economic benefits in scale-up and manufacturing, and environmental/sustainability benefits.
Finally, why should people attend CPHI NA?
It’s a “one stop shop” for professional and business development!
Related News
-
News On Track at Pharmapack 2024 - The Track Sponsor interview: BD Pharmaceuticals
January 2024 brings both a new year and Europe’s leading packaging and drug delivery event. Bringing the world’s experts in pharmaceutical packaging together in Paris, France, Pharmapack 2024 brings exciting opportunities to learn and colla... -
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News Roche breaks into the obesity drug market with the acquisition of Carmot Therapeutics
In a bid to diversify their therapeutic offerings, Roche takes over Carmot Therapeutics in $2.7 billion deal, with one obesity drug spearheading the venture into the field as they prep for a Phase II in-human trial. -
News Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies. -
News Women in Pharma: Delivering solutions for gender diversity
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona Speaker Interview – What the US FDA’s Quality Management Maturity Means for the Pharma Industry
At CPHI Barcelona (24–26 October, 2023), we spoke to Sireesha Yadlapalli, CEO of Pharmatech Associates, who gave a presentation on the implications of the US FDA’s Quality Management Maturity (QMM) Initiative, and spoke on the panel of the ... -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News Wegovy and weight-loss drugs driving demand for manufacturers that can fill syringes
Injectable weight-loss treatments are prompting contract manufacturers to invest and include fill-finish services into their service portfolios, in a bid to attract pharmaceutical giants developing drugs similar to Novo Nordisk's Wegovy.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance